ReachRxResearch
Home
Research
Sign Up
Study limitation
Back to Research Hub
  1. Home
  2. Research Hub
  3. Study limitation

Alzheimer’s disease target and drug discovery by leveraging multiomics and electronic health data

Study limitation reported by the research below: “The pharmacoepidemiology cohort (Optum CDM) is limited to commercially insured US individuals and Medicare Advantage beneficiaries, which may limit generalizability to uninsured or non-US populations.”

Papers